CenterWatch

Home » Clinical Trials » Therapeutic Areas

Therapeutic Areas: Hematology
Disease Category: Hematological Disorders
Location: United States, WV

Clinical Trial Details

Overview

Research Study Summary

WVU011012 - Phase II study of Atorvastatin, micro-dose methotrexate and tacrolimus administered only to transplant recipients for the prophylaxis of acute graft-versus-host disease following matched sibling hematopoietic cell transplantation

Purpose

Objective is to determine the efficacy of an atorvastatin/tacrolimus/methotrexate regimen in preventing grade II-IV acute GVHD in patients undergoing matched-sibling allogeneic hematopoietic stem cell transplantation (HSCT).

See www.hsc.wvu.edu/mbrcc/ctru/ for additional information

To Learn more

CW ID:183642
Date Last Changed: July 16, 2013

Clinical Trial Snapshot

Phase
3
Gender
Both Male and Female
Age
N/A
Overall Status
Recruiting
Facility Type
N/A

Contact

West Virginia University - Clinical Trials Research Unit
1637 Health Sciences South, PO Box 9260
Morgantown, WV 26506
Phone: 304-293-7374

View Map

DISCLAIMER: CenterWatch does not conduct clinical research. CenterWatch is a publishing company that posts clinical trials information on behalf of sponsor companies, contract research organizations, clinical research sites and other interested parties. This information is designed to help patients find clinical trials of interest and contact the research centers conducting the trials.